ACC: Cannabis Tied to Higher Odds for Stroke, Heart Failure

Share this content:
ACC: Cannabis Tied to Higher Odds for Stroke, Heart Failure
ACC: Cannabis Tied to Higher Odds for Stroke, Heart Failure

FRIDAY, March 10, 2017 (HealthDay News) -- Cannabis use may raise an adult's risk of stroke and heart failure, according to research being presented at the upcoming annual meeting of the American College of Cardiology, to be held from March 17 to 19 in Washington, D.C.

Aditi Kalla, M.D., a cardiologist at Einstein Medical Center in Philadelphia, and colleagues looked at 20 million health records of patients aged 18 to 55 who were discharged from one of more than a thousand hospitals across the United States in 2009 and 2010. Of those patients, 1.5 percent said they'd used cannabis.

Such use was associated with a much higher risk for stroke, heart failure, coronary artery disease, and sudden cardiac death. Cannabis use was also tied to common heart disease risk factors such as obesity, high blood pressure, smoking, and drinking, the researchers said. After adjusting for those risk factors, the researchers concluded that cannabis use was independently associated with a 26 percent increased risk of stroke and a 10 percent increased risk of heart failure.

"More research will be needed to understand the pathophysiology behind this effect," Kalla said in a news release from the American College of Cardiology.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »